Literature DB >> 3109572

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma.

J M Parkin, L J Eales, A R Galazka, A J Pinching.   

Abstract

Six patients with the acquired immune deficiency syndrome (AIDS) had exacerbations or recurrences of previously quiescent atopic disease when they developed immunodeficiency. Four developed a different atopic illness from that suffered previously. Atopic symptoms developed within three months after the patients developed AIDS or during prodromal illness. Two of the patients were treated with recombinant interferon gamma: both showed a striking improvement in symptoms and cellular immunity. These results indicate that cellular immunity, through interferon gamma, may have a role in regulating atopic disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109572      PMCID: PMC1246352          DOI: 10.1136/bmj.294.6581.1185

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

Review 1.  Regulation of IgE synthesis.

Authors:  K Ishizaka
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 2.  AIDS and the spectrum of HTLV-III/LAV infection.

Authors:  A J Pinching; R A Weiss
Journal:  Int Rev Exp Pathol       Date:  1986

3.  Microbicidal activity of monocyte derived macrophages in AIDS and related disorders.

Authors:  L J Eales; O Moshtael; A J Pinching
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

4.  Acquired immunodeficiency syndrome in infants.

Authors:  G B Scott; B E Buck; J G Leterman; F L Bloom; W P Parks
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

  4 in total
  12 in total

1.  Interferon for treatment.

Authors:  A Galazka; E Scott
Journal:  BMJ       Date:  1988 Aug 20-27

Review 2.  Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 3.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Gummatous lesions in men infected with human immunodeficiency virus and syphilis.

Authors:  P E Hay; F W Tam; V S Kitchen; S Horner; J Bridger; J Weber
Journal:  Genitourin Med       Date:  1990-10

5.  Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome.

Authors:  G Del Prete; A Tiri; E Maggi; M De Carli; D Macchia; P Parronchi; M E Rossi; M C Pietrogrande; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Formation of IgE-binding factors by T cells of patients infected with human immunodeficiency virus type 1.

Authors:  C Carini; J Margolick; J Yodoi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient.

Authors:  H Albrecht; H J Stellbrink; G Gross; B Berg; U Helmchen; H Mensing
Journal:  Clin Investig       Date:  1994-12

9.  Epidermal barrier dysfunction in non-atopic HIV: evidence for an "inside-to-outside" pathogenesis.

Authors:  Roshan Gunathilake; Matthias Schmuth; Tiffany C Scharschmidt; Robert Gruber; Daniela Grabher; Kieron S Leslie; Toby A Maurer; Theodora M Mauro; Peter M Elias
Journal:  J Invest Dermatol       Date:  2009-11-19       Impact factor: 8.551

10.  Anti-IL-4 monoclonal antibody and IFN-gamma administration retards development of immune dysfunction and cytokine dysregulation during murine AIDS.

Authors:  Y Wang; S K Ardestani; B Liang; C Beckham; R R Watson
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.